Bleichroeder’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.15M Sell
236,842
-500,000
-68% -$2.08M 0.11% 71
2026
Q2
$3.03M Hold
736,842
– – 0.54% 27
2026
Q1
$3.35M Hold
736,842
– – 0.58% 23
2025
Q4
$1.48M Hold
736,842
– – 0.26% 31
2025
Q3
$1.22M Hold
736,842
– – 0.24% 33
2025
Q2
$694K Hold
736,842
– – 0.17% 37
2025
Q1
$723K Buy
+736,842
New +$823K 0.19% 33

Other funds holding IRD

Bleichroeder's IRD Position: Q3 2026 in Review

Bleichroeder reduced its Opus Genetics (IRD) stake by 68% in Q3 2026, selling an estimated $2.08M and leaving 236,842 shares worth $1.15M. The position accounts for 0.11% of the portfolio, ranked #71.

Bleichroeder first reported a position in IRD in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.35M in Q1 2026. 74 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Bleichroeder held 236,842 shares of Opus Genetics worth $1.15M as of Q3 2026.
  • Bleichroeder sold 500,000 Opus Genetics shares in Q3 2026, an estimated $2.08M.
  • Opus Genetics made up 0.11% of Bleichroeder's portfolio in Q3 2026, its #71 holding.
  • Bleichroeder first reported a position in Opus Genetics in Q1 2025 and has held it in 7 quarters since.
  • Bleichroeder's Opus Genetics position peaked at $3.35M in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.